Caricamento...

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD

Along the obesity pandemic, the prevalence of non-alcoholic fatty liver disease (NAFLD), often regarded as the hepatic manifestation of the metabolic syndrome, increases worldwide representing now the prevalent liver disease in western countries. No pharmacotherapy is approved for the treatment of N...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Endocrinol (Lausanne)
Autori principali: Seghieri, Marta, Christensen, Alexander S., Andersen, Andreas, Solini, Anna, Knop, Filip K., Vilsbøll, Tina
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2018
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6232120/
https://ncbi.nlm.nih.gov/pubmed/30459715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00649
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !